2022
DOI: 10.1016/j.drugpo.2022.103589
|View full text |Cite
|
Sign up to set email alerts
|

The state of science on including inhalation within supervised consumption services: A scoping review of academic and grey literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 62 publications
0
8
0
2
Order By: Relevance
“…Worse, it appears that many PWUD in Canadian settings have actively switched from opioid use by injection to inhalation or alternative use modes as part of intentional efforts for improved health protection amidst the drug‐death‐crisis, while with limited success of achieving these desired benefits [28]. Meanwhile, principal interventions (e.g., supervised consumption services) operating across Canada to provide ‘safer’ drug use environments for overdose death reduction, to a large extent, do not accommodate for drug ‘inhalation’, and so leave tangible prevention opportunities for PWUD especially with non‐injection use limited, despite great and acute need to protect and support their health [29]. While related provisions exist in some supervised consumption service sites, these need to be systematically expanded to accommodate and directly support the risk‐reduction needs of PWUD engaging in non‐injection (e.g., inhalation) use.…”
Section: Resultsmentioning
confidence: 99%
“…Worse, it appears that many PWUD in Canadian settings have actively switched from opioid use by injection to inhalation or alternative use modes as part of intentional efforts for improved health protection amidst the drug‐death‐crisis, while with limited success of achieving these desired benefits [28]. Meanwhile, principal interventions (e.g., supervised consumption services) operating across Canada to provide ‘safer’ drug use environments for overdose death reduction, to a large extent, do not accommodate for drug ‘inhalation’, and so leave tangible prevention opportunities for PWUD especially with non‐injection use limited, despite great and acute need to protect and support their health [29]. While related provisions exist in some supervised consumption service sites, these need to be systematically expanded to accommodate and directly support the risk‐reduction needs of PWUD engaging in non‐injection (e.g., inhalation) use.…”
Section: Resultsmentioning
confidence: 99%
“…Dies erleichtert den Wechsel vom injizierendem zum nicht-injizierenden Konsum von Substanzen und reduziert somit die Risiken der Ansteckung mit Infektionskrankheiten (HIV und Hepatitis C) und die Gefahr einer Überdosierung [11]. DKR mit Inhalationsplätzen bieten zudem Konsument*innen von Drogen, die hauptsächlich geraucht werden, sowie Crack einen sicheren Raum für den Konsum [12].…”
Section: Introductionunclassified
“…Auch europaweit wird ein Anstieg von Stimulanzien wie Crack und Methamphetaminen beobachtet [17]. Generell ist wenig über die Nutzung von nicht injizierten Substanzen in Drogenkonsumräumen bekannt [12].…”
Section: Introductionunclassified
“…In Canada, Supervised Consumption Sites (SCS) are federally sanctioned facilities that provide safe and hygienic spaces for people to consume substances in the presence of a staff who is trained in overdose response (3). While the uptake of SCS has gained momentum across the globe with over 130 sites operating in 12 countries (especially in North America, UK, and Europe) due to their researched effectiveness (4), they continue to face signi cant objections and ambivalence from the general public (5).…”
Section: Introductionmentioning
confidence: 99%